Navamedic ASA: Q3 2017 results
Oslo, November 10, 2017 - Navamedic ASA (OSE: NAVA), reported revenues of NOK 44.9 million in the third quarter of 2017, down from NOK 65.2 million in the same period in 2016, following the planned discontinuation of the Aspen agreement. Excluding Aspen, the revenues for the quarter was up 52% to NOK 43 million. Navamedic is also reviewing strategic alternatives, including partnering and co-investments, to accelerate and leverage the Sippi® growth opportunity. "The third quarter marks the first period following the discontinuation of the Aspen agreement, which is reflected in the